Contract facts
NONENo full NAICS 621511 intel page yet. Browse NAICS intelligence
ALLOSURE KIDNEY TEST is a federal NONE award for 246-Network Contracting Office 6 (36C246) held by Caredx, Inc. Estimated value $248K ($171K obligated). Current period of performance ends Oct 18, 2027. Last award drew 1 bidder. Place of performance: BRISBANE CA. Related solicitation 36C24622Q1194.
Recompete timing
PublicCurrent PoP ends Oct 18, 2027 (423 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordCaredx, Inc — $10.5M obligated across 27 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24623P0011?
36C24623P0011 (Allosure KIDNEY TEST) is a 246-Network Contracting Office 6 (36C246) award with a potential value of $248K, currently held by Caredx, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C246-23-P-0011?
36C246-23-P-0011 is the dashed form of PIID 36C24623P0011 (Allosure KIDNEY TEST), held by Caredx, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24623P0011?
246-Network Contracting Office 6 (36C246) awarded 36C24623P0011 to Caredx, Inc (potential $248K).
Who is the incumbent on 36C24623P0011?
Caredx, Inc is the incumbent with $10.5M across 27 related awards in SCOUT’s public footprint. The current period of performance ends Oct 18, 2027.
When does Caredx, Inc’s 36C24623P0011 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 18, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
